News & Events
November 2014 - Newsletter
Nov 2014 - NewslettersDownload the file »
Vaccine Safety Seminar - held on 29 October 2014
Oct 2014 - Events
This seminar brought together researchers, immunisation providers and public health staff interested in active surveillance for adverse events following immunisation (AEFI).
The focus of the seminar was to discuss and improve upon current methods of active and enhanced surveillance and to strengthen collaborative efforts across state, territory and national systems to improve vaccine safety surveillance.
Methods of active and enhanced surveillance, including solicited feedback via SMS, hospital-based surveillance for adverse events of special interest, and use of large health care databases; the role of the public and healthcare providers in AEFI surveillance and international models.
The opening address was provided by Prof Chris Baggoley, Chief Medical Officer, who gave an overview of vaccine safety surveillance in Australia in recent years.
International guest speaker Jennifer Nelson, PhD
Group Health Research Institute, University of Washington, Seattle, WA
National speakers included A/Prof Michael Gold (member of the Global Advisory Committee on Vaccine Safety of the WHO); Dr Jim Buttery (Director of SAEFVIC), Prof Paul Effler (WA Department of Health), Dr Alan Leeb (General Practitioner, WA) and Dr Tony Hobbs (Therapeutic Goods Administration)
PDFs of selected presentations given on the day are available via the individual links below. Please note files are large and may take a couple of minutes to download.
Overview of systems for active post-marketing surveillance in the USA AND Using large healthcare databases in the USA to assess vaccine safety - by Jennifer Nelson
What is active surveillance and how does this complement passive surveillance? - by Kristine Macartney
Why should we engage our patients in vaccine pharmacovigilance? Clinician researcher perspective - by Chris Blyth
Influenza vaccine safety surveillance in Western Australia - by Annette Regan
Vaxtracker: a web-based survey tool for vaccine safety - by Patrick Cashman
Going National: AusVaxSafety 2014 and beyond - by Gulam Khandaker
Hospital-based sentinel surveillance for AEFI - the PAEDS network - by Nick Wood
Sentinel site surveillance for rare complex conditions and the power of international collaboration - by Nigel Crawford
Can automated data from Emergency Department data collections help to assess vaccine safety - by Jim Buttery
GP encounter data to assess vaccine safety - by Rob Menzies
Click here for a PDF version of the program with speaker profiles
August 2014 - Newsletter
Aug 2014 - NewslettersDownload the file »
December 2013 - Newsletter
Dec 2013 - NewslettersDownload the file »
November 2013 - E-Newsletter
Nov 2013 - NewslettersDownload the file »
October 2013 - E-Newsletter
Oct 2013 - NewslettersDownload the file »
September 2013 - Newsletter
Sep 2013 - NewslettersDownload the file »
September 2013 - E-Newsletter
Sep 2013 - NewslettersDownload the file »
August 2013 - Newsletter
Aug 2013 - NewslettersDownload the file »
2010 Annual immunisation coverage report
Apr 2013 - News
The most recent data on the uptake of vaccines available to Australian children under the National Immunisation Program (NIP) have recently been published in the 2010 annual immunisation coverage report.
The yearly report analyses data available through the Australian Childhood Immunisation Register (ACIR) and comments on the coverage of NIP listed vaccines at the different age milestones and trends in timeliness of vaccine delivery. Vaccine uptake is also assessed with respects to Indigenous status and geographical locations.
The 2010 report demonstrates the success of the Australian Childhood Immunisation Program, with national coverage for all vaccines recommended for children at 12 months and 24 months of age, exceeding the Immunise Australia coverage targets of 90%.
However, the report also identifies areas where immunisation coverage can be improved. A disparity still exists in vaccine coverage between Indigenous and non-Indigenous children, especially with regards to timeliness of vaccine delivery. A number of geographical areas have also been identified throughout Australia where immunisation coverage is lower than the national average.
The full report is available online in the March 2013 issue of Communicable Disease Intelligence (CDI) on the Australian Government Department of Health and Ageing website. The report is prepared by the Surveillance team at the National Centre for Immunisation Research and Surveillance.
Prev 1 2 3 4 5 6 7 8 9 10 11 Next